Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > BOLD MOVE TO RELEASE QTR END 31-10-2022 !
View:
Post by august202013 on Dec 30, 2022 10:31pm

BOLD MOVE TO RELEASE QTR END 31-10-2022 !

CORRECT CURRENT NET LOSS OF $632.449 IS NOT GOOD BUT APPEARS THE WORST IS OVER AND BOLD MOVE TO RELEASE QUARTERLY END 31-10-2022 !

AS EXPLAINED IS ATTRIBUTED TO COST ASSOCIATED WITH OBTAINING REGULATORY APPROVAL AND PRODUCT DEVELOPMENT WORK. REASONABLE AND MAKE SENSE.

RELATIVELY CLEAN SUMMARY P & L AND  AGAIN APPEARS THE WORST MAYBE OVER !

HOPEFULLY HC IS ON THE WAY TO BEIJING WITH THE VYRA

SHOULD SEE SOME MORE VOLUME TOMORROW HOPEFULLY EXCEEDING TODAY'S
526,939.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities